Of the participants, 1.4% had AMD, 58.1% had hypertension, 48.9% used aspirin regularly, and 41.2% used multivitamins regularly. Patients were randomized to cocoa flavanols 500 mg/day, including ...

Dual antiplatelet therapy (DAPT) with aspirin (100 mg) combined with clopidogrel (75 mg ... a favorable outcome between the non-ISS group (82.1%) and the ISS group (87%) (P=0.32). There were no ...

The combination with multi-modal imaging and serological markers enhanced both the sensitivity (87.31%) and specificity (92.31 ... Postoperatively, patients were treated with Aspirin (Bayer, Germany) ...

All patients were pretreated with aspirin 325 mg and clopidogrel 75 mg for 5 days or loaded ... Stenting was unilateral in 13 of the 15 patients (87%) and bilateral in two (13%). Clinical follow-up ...

For predicting preeclampsia, MAP had AUCs of 0.86 (95% CI 0.78 to 0.95), 0.87 (95% CI 0.80 to 0.95 ... urinary albumin ≥300 mg/24 hours urine collection or ≥1+ dipstick. For women with chronic ...

Figure 4. In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control. (A) Representative maximum-intensity projection (MIP) and axial PET/CT images ...

will compare the pharmacokinetic and pharmacodynamic characteristics of normal healthy adult volunteers administered a sublingual dose of 162.5 mg aspirin powder with control healthy subjects ...

The phase 1 clinical trial, which is being conducted in the United States, will compare the pharmacokinetic and pharmacodynamic characteristics of normal healthy adult volunteers administered a ...

will compare the pharmacokinetic and pharmacodynamic characteristics of normal healthy adult volunteers administered a sublingual dose of 162.5 mg aspirin powder with control healthy subjects ...

The Phase 1 clinical trial, which is being conducted in the United States, will compare the pharmacokinetic and pharmacodynamic characteristics of normal healthy adult volunteers administered a ...